window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 27, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Research & Development

  • Artificial Intelligence,Genomics and sequencing,Metabolic Diseases,Obesity,Research & Development

    Insitro completes first AI-enabled human genetics study of brown adipose tissue, identifies differentiated obesity targets

    insitro has completed what it says is the first population-scale [...]

    February 3, 2026
  • Cell & Gene Therapy,Clinical Development,Oncology,Partnerships & Funding,Research & Development

    Affibody advances radioligand therapies for precision oncology

    On World Cancer Day (WCD), Affibody highlights its progress in [...]

    February 4, 2026
  • Cell & Gene Therapy,Clinical Development,Oncology,Partnerships & Funding,Research & Development

    CuraCell highlights T-cell therapy advances for solid tumors on World Cancer Day

    On World Cancer Day (today, February 4), CuraCell highlights its [...]

    February 4, 2026
  • Clinical Development,Clinical Trials,Oncology,Pharmaceuticals and therapeutics,Precision medicine,Research & Development

    Molecular Partners shares first patient imaging and dosimetry results for new cancer radiotherapy

    Molecular Partners has presented first patient imaging and dosimetry data [...]

    February 2, 2026
  • Biotech,Clinical Development,European biotech,Immunology,Oncology,Partnerships & Funding,Research & Development

    Kahimmune Therapeutics signs exclusive licensing agreement with Gustave Roussy and SATT Paris-Saclay

    Kahimmune Therapeutics has signed an exclusive licensing agreement with Gustave [...]

    February 2, 2026
  • Clinical studies,Dermatology,Research & Development

    Study sheds light on how picosecond lasers work in pigmentation disorders and skin ageing

    A new preclinical study using a porcine skin model has [...]

    February 2, 2026
  • Central Nervous System,Clinical Trials,Drug Development,Rare Diseases,Research & Development

    Skyhawk Therapeutics reports positive nine-month interim results for SKY-0515 in Huntington’s disease

    Skyhawk Therapeutics has reported positive nine-month interim results from its [...]

    January 29, 2026
  • Biologics & Biosimilars,Cell & Gene Therapy,Clinical Development,Drug Development,Rare Diseases,Research & Development

    iXCells Biotechnologies partners with Rosebud Biosciences to advance organoid models for rare diseases

    iXCells Biotechnologies and Rosebud Biosciences have announced a partnership to [...]

    January 29, 2026
  • Clinical studies,Drug Development,Oncology,Precision medicine,Research & Development

    Nine-gene signature linked to lapatinib resistance in HER2-positive breast cancer

    Researchers at City St George’s, University of London have identified [...]

    January 29, 2026
  • Clinical Development,Clinical studies,Drug Delivery & Formulation,European biotech,Obesity,Research & Development

    Nanexa targets next-generation ‘fat jab’ with monthly semaglutide delivery platform

    Sweden-based Nanexa has reported preclinical data for a long-acting semaglutide [...]

    January 29, 2026
Previous789Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • William Blair highlights Carterra as key player in AI-driven drug discovery shift
    Categories: Artificial Intelligence, Drug Development, Drug discovery, Research & Development, Technology and platforms
  • 23andMe study links genetics to GLP-1 weight loss outcomes and side effects
    Categories: Artificial Intelligence, Clinical Development, Genomics and sequencing, Obesity, Precision medicine, Technology and platforms
  • Life Biosciences raises $80M to advance gene therapy for optic neuropathies
    Categories: Clinical Trials, Funding, Opthalmology, Pharmaceuticals and therapeutics, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top